BRIEF published on 12/05/2025 at 18:39, 10 months 1 day ago Valneva Updates Share and Voting Rights as of November 2025 Stock Options Euronext Paris Voting Rights Valneva Double Voting Rights
BRIEF published on 12/05/2025 at 18:39, 10 months 1 day ago Valneva met à jour ses actions et ses droits de vote à compter de novembre 2025 Euronext Paris Options D'achat D'actions Droit De Vote Valneva Double Droit De Vote
PRESS RELEASE published on 12/05/2025 at 18:34, 10 months 1 day ago VALNEVA Déclaration d’actions et de droits de vote : 30 novembre 2025 VALNEVA déclare des actions et des droits de vote, dont un passage en droit de vote double et un exercice d'options de souscription d'actions. Informations sur le siège social et le marché réglementé Euronext Paris Déclaration Droits De Vote Actions Valneva
PRESS RELEASE published on 12/05/2025 at 18:34, 10 months 1 day ago VALNEVA Declaration of shares and voting rights: November 30, 2025 VALNEVA declares changes in shares and voting rights, including double voting rights granted on ordinary shares and transfer into bearer form Euronext Paris Voting Rights Shares Valneva Double Voting Rights
BRIEF published on 12/03/2025 at 11:03, 10 months 3 days ago Valneva SE: Promising Developments in Lyme Disease Vaccine Valneva SE Lyme Disease Vaccine Market Forecast Pfizer VLA15
BRIEF published on 12/03/2025 at 11:03, 10 months 3 days ago Valneva SE : Développements prometteurs dans le domaine du vaccin contre la maladie de Lyme Valneva SE Vaccin Contre La Maladie De Lyme Prévisions Du Marché Pfizer VLA15
PRESS RELEASE published on 12/03/2025 at 10:58, 10 months 3 days ago Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research updates Buy recommendation for Valneva SE, raising target price to €6.80. VLA15 vaccine progress and market potential analyzed Buy Recommendation Research Update Valneva SE Market Potential VLA15 Vaccine
BRIEF published on 11/04/2025 at 07:05, 11 months 2 days ago Valneva's Phase 1 Trial Yields Positive Results for Zika Vaccine Phase 1 Trial Valneva Immunogenicity Zika Vaccine Adjuvant
BRIEF published on 11/04/2025 at 07:05, 11 months 2 days ago L'essai de phase 1 de Valneva donne des résultats positifs pour le vaccin contre le Zika Valneva Immunogénicité Essai De Phase 1 Adjuvant Vaccin Contre Le Zika
PRESS RELEASE published on 11/04/2025 at 07:00, 11 months 2 days ago Valneva annonce des résultats positifs de Phase 1 pour son candidat vaccin de deuxième génération contre le virus Zika Valneva annonce des résultats positifs de phase 1 pour son candidat vaccin de deuxième génération contre le virus Zika, montrant une réponse immunitaire améliorée Valneva Immunitaire Phase 1 Vaccin Zika
Published on 10/07/2026 at 01:45, 5 hours 8 minutes ago Final Tunkillia Assays Among the Best Infill Results To-Date, with Broad, High-Grade Intersections Throughout 'Starter Pit' Outlines
Published on 10/07/2026 at 01:30, 5 hours 23 minutes ago ECC Ventures 4 Corp. Announces Resumption of Trading
Published on 10/07/2026 at 01:05, 5 hours 48 minutes ago Alaska Energy Metals Reports on At-The-Market Equity Financing Program
Published on 10/06/2026 at 23:45, 7 hours 8 minutes ago Gamma Resources Closes $1,750,000 Private Placement
Published on 10/06/2026 at 23:32, 7 hours 21 minutes ago Battery X Metals Announces Closing of First Tranche of Private Placement Financing
Published on 10/07/2026 at 06:30, 23 minutes ago Global Youth Powerhouse Summit 2026 Concludes Successfully
Published on 10/06/2026 at 19:05, 11 hours 47 minutes ago Cambridge Heartwear Awarded £184 Million NHS Tender for World's First Medical-Grade, Wirelessly Charged, Reusable ECG Wearable
Published on 10/06/2026 at 18:30, 12 hours 23 minutes ago Avolta’s Hudson secures new 20-year duty-free contract at Seattle-Tacoma International
Published on 10/06/2026 at 18:05, 12 hours 48 minutes ago Lepermislibre: INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL
Published on 10/06/2026 at 18:00, 12 hours 53 minutes ago ARVERNE GROUP: Nombre total de droits de vote et d’actions composant le capital social au 30 septembre 2026
Published on 10/06/2026 at 19:15, 11 hours 38 minutes ago Air Liquide has successfully issued a 2 billion euros multi-tranche bond
Published on 10/06/2026 at 19:15, 11 hours 38 minutes ago Air Liquide a réalisé avec succès une émission obligataire multi-tranches de 2 milliards d’euros
Published on 10/06/2026 at 18:39, 12 hours 13 minutes ago Capital et droits de vote au 30 septembre 2026
Published on 10/06/2026 at 18:39, 12 hours 13 minutes ago Total number of voting rights and shares making up the share capital at September 30, 2026
Published on 10/06/2026 at 18:15, 12 hours 38 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 30/09/2026
